Paper Review Records
全部论文审稿周期
30 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接
237
天
Ex vivo JAK and TNF inhibitor–modulated immune signatures guide first-line therapy selection in rheumatoid arthritis
作者
Sagrario Corrales; Carlos Pérez-Sánchez; Tomas Cerdó; Christian Merlo; Beatriz Malvar-Fernández; Samuel García; Laura Muñoz-Barrera; Ismael Sanchez-Pareja; Lydia Formanti; Elena Moreno-Caño; Rafaela Ortega-Castro; Jerusalén Calvo; Concepción Aranda-Varela; Lourdes Ladehesa; Pilar Font; M. Carmen Abalos-Aguilera; Desirée Ruiz-Vilchez; Mª Ángeles Aguirre; Nuria Barbarroja; Marta E. Alarcon-Riquelme; Alejandro Escudero-Contreras; Chary López-Pedrera展开收起
作者单位
1. IMIBIC/Reina Sofia Hospital/University of Cordoba, Córdoba, Spain; 2. Department of Cell Biology, Immunology and Physiology, Agrifood Campus of International Excellence, University of Córdoba, Córdoba, Spain; 3. Cobiomic Bioscience, EBT IMIBIC/UCO, Córdoba, Spain; 4. Rheumatology and Immuno-Mediated Diseases Research Group (IRIDIS), Galicia Sur Health Research Institute (IIS Galicia Sur), SERGAS-UVIGO, Vigo, Spain; 5. Center for Genomics and Oncological Research (GENYO), Granada, Spain; 6. Institute for Environmental Medicine, Stockholm, Sweden展开收起
72
天
Persistent CAR-T donor cells contribute to mixed chimerism with cytopenia after CAR-T-bridged allo-HSCT: rescue by CAR-target-knockout DLI in three cases
作者
Yi Liu; Zelin Wang; Yamei Wu; Xiuwen Xu; Xiaoxia Hu; Jing Pan展开收起
作者单位
1. Senior Department of Hematology, Fifth Medical Center of Chinese PLA General Hospital, Beijing, China; 2. Department of Hemato-oncology and Immunotherapy, Beijing Gobroad Hospital, Beijing, China; 3. Department of Medical Laboratory, Beijing Gobroad Boren Hospital, Beijing, China; 4. State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China; 5. State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China展开收起
80
天
Targeting myeloid cell plasticity and metabolic reprogramming to alleviate T cell dysfunction and exhaustion-associated states and enhance immune checkpoint blockade therapy
作者
Mingxing Wang; Jian Chen; Zhonghua Wu; Zhiying Wang; Zhixian Zhong; Yi Zhong展开收起
作者单位
1. Shanghai TCM-Integrated Hospital, Shanghai University of TCM, Shanghai, China; 2. Shanghai University of Traditional Chinese Medicine, Shanghai, China; 3. Tongji University, Shanghai, China展开收起
112
天
Dynamic regulation of H3K9 modifications in cancer: pathogenesis and targeted therapies
作者
Yuanyuan Xu; Qihui Wu; Yuxiu Zhang; Jitong Zhao; Xiaodan Fu; Anqi Li; Yimin Li展开收起
作者单位
1. Department of Pathology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China; 2. Department of Gynecology, Xiangya Hospital, Central South University, Changsha, China; 3. National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Changsha, China; 4. Department of Pathology, Zhongshan Hospital, Fudan University, Shanghai, China; 5. Department of Pathology, Xiangya Hospital, Central South University, Changsha, China展开收起
48
天
AI-driven precision immunotherapy: emerging trends from AACR 2026
作者
Yani Chen; Ming Chen; Yiqing Xi; Yun Xia; Siyuan Ma; Baoxiang Chen展开收起
作者单位
1. School of Medicine, Sun Yat-Sen University, Shenzhen, China; 2. Department of Nephrology, Wuhan Third Hospital (Tongren Hospital of Wuhan University), Wuhan, China; 3. Department of Nephrology, Zhongnan Hospital of Wuhan University, Wuhan, China; 4. Department of Head and Neck Surgery, Tongji Medical College, Hubei Cancer Hospital, Huazhong University of Science and Technology, Wuhan, China; 5. Department of Anesthesiology, Zhongnan Hospital of Wuhan University, Wuhan, China; 6. Electrical and Electronic Engineering, Nanyang Technological University, Singapore, Singapore; 7. Hubei Key Laboratory of Intestinal and Colorectal Diseases, Zhongnan Hospital of Wuhan University, Wuhan, China; 8. Clinical Center of Intestinal and Colorectal Diseases of Hubei Province, Zhongnan Hospital of Wuhan University, Wuhan, China; 9. Rosalind and Morris Goodman Cancer Institute, McGill University, Montreal, Canada展开收起
54
天
Beyond hypoxia and ccRCC: the expanding universe of VHL novel targets and next-generation therapeutics
作者
Ruiyi Deng; Boyuan Wang; Mingrui Zou; Kaiyuan Mao; Jiaheng Shang; Jianhui Qiu; Jingcheng Zhou; Hua Xu; Xin Ma; Yizhou Wang; Lin Cai; Kan Gong展开收起
作者单位
1. Department of Urology, Peking University First Hospital, Beijing, China; 2. Institute of Urology, Peking University, Beijing, China; 3. Beijing Key Laboratory of Precision Medicine and Innovative Translation for Urogenital Diseases, Beijing, China; 4. National Urological Cancer Center, Beijing, China; 5. Peking University Health Science Center, Beijing, China; 6. Department of Urology, Zhongnan Hospital of Wuhan University, Wuhan, China; 7. Taikang Center for Life and Medical Sciences, Wuhan University, Wuhan, China; 8. Senior Department of Urology, Chinese PLA General Hospital, Beijing, China; 9. Department of Central Laboratory, Peking University First Hospital, Beijing, China展开收起
Expert Matching · Case Demo
把投稿要求,转成可验证的期刊方案
说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。
